Education is a key component of the services offered through the the Office. There are several educational opportunities provided throughout the year. In particular, our Emory Patent Group presents semi-annual seminars related to intellectual property protection. When feasible and appropriate these educational sessions are recorded and posted here for future viewing. We hope you find them helpful. If you don't find the answer to your question please contact us at either 404-727-2211 or contact us.

Watch the website or check out our Twitter feed or blog site for announcements regarding educational opportunities.

Position Your Research

More attention at the national and global levels is being paid to inventions from basic research and their ability to translate into commercial successes. Governments, at all levels, are establishing funds for translational and applied research. Position yourself to utilize these funds and attract commercial partners. Please join us for OTT’s four-part innovator series!

Session 1: Identify industry needs that align with your interests

Presented by Emory Office of Technology Transfer on 2/27/2014

Companies are looking for inventions that perform better, faster, or cheaper than what is currently available. In this seminar keynote speaker Merrick Furst, PhD, (Founder Flashpoint at Georgia Tech) who helps develop and produce technology startup companies, will speak about methods to discover what products are already available, identify unmet needs in the industry, and design experiments to solve them.

Session 2: Design research aims around commercially-relevant milestones

Presented by Emory Office of Technology Transfer on 3/27/2014

To pursue commercial development, industry often expects specific outcomes. These outcomes could require the use of a specific disease model, available treatments as controls for comparison, or a favorable safety profile. In this seminar our moderator Philip Semprevio, JD, Licensing Associate will lead a panel consisting of Brad Hubbard, DVM, T3 Labs; Martin Moore, PhD, Emory; and Michael Natchus, PhD, MBA, Emory EIDD in discussing these experiments and their benefits for overall project completeness, commercial partners, and patent protection.


Session 3: Position your research for translational funding

This seminar will discuss strategies to better position your resarch to receive translation funding by knowing what the people who make these decisions are looking for and how to respond to their concerns. In this seminar our moderator Panya Taysavang, MBA, Licensing Associate will lead a panel consisting of Lee Herron, DVM, Georgia Research Alliance; H. Trent Spencer, PhD, Expression Therapeutics; and Kevin Lei, Director, OTT, Emory in discussing the sources that fund translation resarch such as the GRA, Coulter Translational Fund, and ACTSI.

Session 4: Commercialize discoveries with the Office of Technology Transfer

This seminar will focus on the path for commercialization of new inventions, from disclosure to OTT through commercial development and how to avoid potential stumbling blocks along the way. Our moderator Todd Sherer, PhD, Executive Director, will lead the panel consisting of Rachael Hagan Tanner, Sr. Program Director, Coulter Translational Resarch Partnership; Randi Isaacs, JD, Patent Cousel, Emory; J. Cale Lennon, PhD, MBA, CLP, Director, OTT, Emory in discussion.

Avoiding the Darkness: Patent Eligibility of Biologicals and Biomarkers

Presented by Emory Office of Technology Transfer on 4/20/2015

OTT’s Emory Patent Group hosted our 4th semi-annual Lunch & Learn seminar with guest speaker Susan Alpert Siegel, Ph.D., Patent Agent from Klarquist Sparkman, LLP.. Susan discussed the recent major changes in the law relating to patenting of diagnostic tests and biologics, with major rulings implicating the patentability of diagnostic methods, genetic sequences, and biomarkers. This seminar will summarize the recent court cases and provide strategies for obtaining value from the development of biologics and biomarkers.

Designing Product Protection?

Presented by Emory Office of Technology Transfer on 4/16/2013

OTT’s Emory Patent Group hosted our 3rd semi-annual Lunch & Learn seminar with guest speakers Tracy-Gene Durkin & Mark Rygiel Directors from Sterne Kessler Goldstein Fox, LLC. Together they discussed how design patents can be used in biomedical and clinical research to facilitate commercial protection of products including devices, software, and new therapeutics. As “ordinary” patent protection in the U.S. today is significantly weaker than it was just a few years ago. In the wake of court decisions and new laws that have limited protection in the medical space and disadvantaged university vis-a-vis industry researchers, design patents have emerged as a key player in new commercialization strategies. The event as popular once again – stay tuned for our next session.

Genes, Biologics, Biomarkers ... Are They Patentable?

Presented by Emory Office of Technology Transfer on 10/12/2012

On October 12th, OTT’s Emory Patent Group hosted our 2nd annual Lunch & Learn seminar with guest speakers William Noonan, MD and Susan Alpert Siegel, PhD, a partner and patent agent respectively, from Klarquist Sparkman, LLP. Together, they discussed requirements for patentability, effects of recent court decisions, and claims and coverage of patents, with emphasis on patents in the biotech arena. The Lunch & Learn Seminar was, once again, hugely popular and we look forward to continuing these biannual seminars in the years to come.

Can You Patent This?

Presented by Emory Office of Technology Transfer on 4/20/2012

On April 20, OTT's Emory Patent Group or hosted its inaugural "EPG Lunch & Learn" seminar on the topic of the Leahy-Smith America Invents Act, otherwise known as the Patent Reform legislation. We were fortunate to have Chris Curfman present key aspects of the legislation and the impact that these could have on the research enterprise. Chris is a principal at Meunier Carlin & Curfman, LLC, (formerly McKeon Carlin & Curfman, LLC) a top local patent law firm, and is also a graduate of the Department of Chemistry at Emory. We are excited to build on the success of this first presentation in our semiannual seminars focusing on high profile topics in intellectual property protection.

Kauffman FastTrac® TechVenture™

For several years Emory has participated in bringing the Kauffman FastTrac® TechVenture™ program to Atlanta. The program is offered on a period basis and participation is through an application process.

The course is designed to help science-based entrepreneurs transform their grand ideas into flourishing businesses. During the 6 week program aspiring and current entrepreneurs learn about the nuts and bolts of running a business from other successful entrepreneurs. Participants will explore market research analysis, financial planning, team building, intellectual property, and business management, among other topics. Each topic will be taught by a different startup executive or an experienced entrepreneur.

Much of the course material comes from the Kauffman Foundation, which supports educational programs promoting entrepreneurship across the country. It will include guest speakers, facilitated discussions, and coaching sessions.

Previously the Kauffman course has been offered in collaboration with the University of Georgia’s Small Business Development Center, Atlanta’s Clinical and Translational Science Institute, and (Small Business Administration).

Visit our blog on Kauffman to learn more about the program.

Commercializing Medical Device Technology Panel

Presented by Emory Office of Technology Transfer and ACTSI on 11/16/11

A panel discussion about commercializing medical device technology followed by a question and answer session. The moderator is Todd Sherer, PhD Associate VP and Exec. Director OTT. The panelist are Jay Yadav, MD, Founder and Chief Executive Officer, CardioMEMS, Inc,; James L. Greene, CEO, Apica Cardiovascular Limited; Scott D. Boden, MD, Director, The Emory Orthopedics & Spine Center; Omar Lattouf, MD, PhD, Professor, Cardiothoracic Surgery, Emory.